Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

terminated125%
completed250%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completed

Delphinus SoftVue Prospective Case Collection - ARM 2

NCT02977247
completed

Delphinus SoftVue Prospective Case Collection - ARM 1

NCT03257839
unknownnot_applicable

Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy

NCT04468867
terminated

Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts

NCT02042456

Clinical Trials (4)

Showing 4 of 4 trials
NCT02977247

Delphinus SoftVue Prospective Case Collection - ARM 2

Completed
NCT03257839

Delphinus SoftVue Prospective Case Collection - ARM 1

Completed
NCT04468867Not Applicable

Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy

Unknown
NCT02042456

Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4